Intrinsiqs

Is OnKure Therapeutics, Inc. overvalued?

OnKure Therapeutics, Inc. (OKUR) — key valuation metrics and fundamentals.

No verdict
Price
$3.99
Fair value
Current P/E
Normal P/E
Market cap
$161.6M
Dividend yield
0.0%
Return on equity
-49.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares OKUR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.